Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Development of metabolic syndrome and its correlation with insulin resistance in adult patients with Turner syndrome

터너증후군을 가진 성인 환자에서 대사증후군의 발생과 인슐린저항성과의 관계

  • Kim, Joo Hwa (Department of Pediatrics, College of Medicine, Seoul National University) ;
  • Kang, Min Jae (Department of Pediatrics, College of Medicine, Seoul National University) ;
  • Shin, Choong Ho (Department of Pediatrics, College of Medicine, Seoul National University) ;
  • Yang, Sei Won (Department of Pediatrics, College of Medicine, Seoul National University)
  • 김주화 (서울대학교 의과대학 소아과학교실) ;
  • 강민재 (서울대학교 의과대학 소아과학교실) ;
  • 신충호 (서울대학교 의과대학 소아과학교실) ;
  • 양세원 (서울대학교 의과대학 소아과학교실)
  • Received : 2008.08.14
  • Accepted : 2008.10.28
  • Published : 2009.03.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : The risk of metabolic syndrome (MS) and cardiovascular disease in Turner syndrome (TS) patients is high. We analyzed metabolic factors in adults with TS and evaluated the metabolic risk of insulin resistance. Methods : Forty-three adults with TS were enrolled. The frequency of MS and the values of the metabolic factors were analyzed. Patients were divided into insulin resistant and non-resistant groups according to values of homeostasis model assessment of insulin resistance (HOMA-IR). The correlations of HOMA-IR with metabolic parameters were analyzed. Results : The frequency of MS was 7% and those of each metabolic parameter were as follows: insulin resistance, 16.3%; central obesity, 15.4%; hypertriglyceridemia, 2.3%; low HDL cholesterol, 9.3%; hypertension, 36.8%. The insulin-resistant group had significantly higher values of body mass index (BMI), waist circumference (WC), fasting plasma glucose (FPG), HOMA-IR, and systolic blood pressure (SBP) than the non-resistant group (P<0.05). HOMA-IR showed a significantly positive correlation with BMI, WC, FPG, and SBP and showed a negative correlation with HDL cholesterol. Conclusion : This study suggests that adults with TS have a high risk of metabolic syndrome, and insulin resistance is correlated with metabolic factors. Therefore, TS patients should have their metabolic parameters monitored regularly to minimize metabolic complications and prevent cardiovascular diseases.

목 적 : 터너증후군 환자에서 대사증후군과 심혈관 질환의 위험성이 높다. 성인 연령의 터너증후군 환자들에서 대사증후군 관련요인을 분석하고, 인슐린 저항성의 대사위험성을 알아보기 위한 연구를 시행하였다. 방 법 : 43명의 성인 터너증후군 환자에서 대사증후군의 빈도와 관련 요인 값들을 분석하였다. HOMA-IR을 이용하여 인슐린 저항성군과 비저항성군으로 분류한 후 각 집단을 분석하고, HOMA- IR과 대사 증후군 관련요인의 상관관계를 알아보았다. 결 과 : 대사증후군은 터너증후군 환자의 7%에서 보였고 각 항목에 대해서 인슐린 저항성은 16.3%, 복부 비만이 15.4%, 고중성지방이 2.3%, 저HDL 콜레스테롤이 9.3%였고, 고혈압이 36.8 %였다. 체질량지수, 허리둘레, 공복 혈당, HOMA-IR, 수축기 혈압은 인슐린 저항성군에서 의미 있게 높게 나왔으며, HOMA-IR은 체질량지수, 허리둘레, 공복 혈당, 수축기 혈압과 양의 상관관계를 보였다(P<0.05). 결 론 : 터너증후군 성인 환자들에서 대사증후군의 위험성이 있으며, 인슐린 저항성과 대사증후군 관련요인 간에 상관관계를 보인다. 터너증후군 환자들에게서 대사관련 요인을 일정기간 마다 검사하여 대사증후군 또는 인슐린 저항성으로의 진행여부를 감시하고 심혈관 합병증을 예방하는 것이 필요하다.

Keywords

References

  1. Gravholt CH. Epidemiological, endocrine and metabolic features in Turner syndrome. Eur J Endocrinol 2004;151:657-87 https://doi.org/10.1530/eje.0.1510657
  2. Nielsen J, Wohlert M. Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet 1991;87:81-3 https://doi.org/10.1007/BF01213097
  3. Ross JL, Feuillan P, Long LM, Kowal K, Kushner H, Cutler GB, Jr. Lipid abnormalities in Turner syndrome. J Pediatr 1995;126:242-5 https://doi.org/10.1016/S0022-3476(95)70551-1
  4. Caprio S, Boulware S, Diamond M, Sherwin RS, Carpenter TO, Rubin K, et al. Insulin resistance: an early metabolic defect of Turner's syndrome. J Clin Endocrinol Metab 1991; 72:832-6 https://doi.org/10.1210/jcem-72-4-832
  5. Cicognani A, Mazzanti L, Tassinari D, Pellacani A, Forabosco A, Landi L, et al. Differences in carbohydrate tolerance in Turner syndrome depending on age and karyotype. Eur J Pediatr 1988;148:64-8 https://doi.org/10.1007/BF00441818
  6. Swerdlow AJ, Hermon C, Jacobs PA, Alberman E, Beral V, Daker M, et al. Mortality and cancer incidence in persons with numerical sex chromosome abnormalities: a cohort study. Ann Hum Genet 2001;65:177-88 https://doi.org/10.1046/j.1469-1809.2001.6520177.x
  7. Gravholt CH, Juul S, Naeraa RW, Hansen J. Morbidity in Turner syndrome. J Clin Epidemiol 1998;51:147-58 https://doi.org/10.1016/S0895-4356(97)00237-0
  8. Virdis R, Cantu MC, Ghizzoni L, Ammenti A, Nori G, Volta C, et al. Blood pressure behaviour and control in Turner syndrome. Clin Exp Hypertens A 1986;8:787-91 https://doi.org/10.3109/10641968609046595
  9. Aligeti VR, Horn HR. Turner's syndrome and coronary artery disease. Am J Cardiol 2007;99:741-2 https://doi.org/10.1016/j.amjcard.2006.10.027
  10. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607 https://doi.org/10.2337/diabetes.37.12.1595
  11. Expert Panel on Detection, Evaluation Treatment of High Blood Cholesterol in, Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97 https://doi.org/10.1001/jama.285.19.2486
  12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9 https://doi.org/10.1007/BF00280883
  13. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9 https://doi.org/10.1001/jama.287.3.356
  14. Park JS, Park HD, Yun JW, Jung CH, Lee WY, Kim SW. Prevalence of the metabolic syndrome as defined by NCEP- ATPIII among the urban Korean population. Korean J Med 2002;63:290-9
  15. Bakalov VK, Cooley MM, Quon MJ, Luo ML, Yanovski JA, Nelson LM, et al. Impaired insulin secretion in the Turner metabolic syndrome. J Clin Endocrinol Metab 2004;89:3516- 20 https://doi.org/10.1210/jc.2004-0122
  16. Cooley M, Bakalov V, Bondy CA. Lipid profiles in women with 45,X vs 46,XX primary ovarian failure. JAMA 2003; 290:2127-8 https://doi.org/10.1001/jama.290.16.2127
  17. Gravholt CH, Naeraa RW, Nyholm B, Gerdes LU, Christiansen E, Schmitz O, et al. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement. Diabetes Care 1998;21:1062-70 https://doi.org/10.2337/diacare.21.7.1062
  18. Elsheikh M, Conway GS. The impact of obesity on cardiovascular risk factors in Turner's syndrome. Clin Endocrinol (Oxf) 1998;49:447-50 https://doi.org/10.1046/j.1365-2265.1998.00552.x
  19. Nathwani NC, Unwin R, Brook CG, Hindmarsh PC. Blood pressure and Turner syndrome. Clin Endocrinol (Oxf) 2000; 52:363-70 https://doi.org/10.1046/j.1365-2265.2000.00960.x
  20. Finegood DT, Hramiak IM, DupreJ. A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes. J Clin Endocrinol Metab 1990;70:1538-49 https://doi.org/10.1210/jcem-70-6-1538
  21. Lebovitz HE. Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes 2001;109(2 Suppl):135S-48S https://doi.org/10.1055/s-2001-18576
  22. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57-63 https://doi.org/10.2337/diacare.23.1.57
  23. Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 2003;26:3320-5 https://doi.org/10.2337/diacare.26.12.3320
  24. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 1998;47:1643-9 https://doi.org/10.2337/diabetes.47.10.1643
  25. Lee S, Choi S, Kim HJ, Chung, YS, Lee KW, Lee HC, et al. Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults. J Korean Med Sci 2006;21:695-700 https://doi.org/10.3346/jkms.2006.21.4.695
  26. Facchini FS, Hua N, Abbasi F, Raven GM. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 2001;86:3574-8 https://doi.org/10.1210/jc.86.8.3574
  27. Yip J, Facchini FS, Reaven GM. Resistance to insulin- mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 1998;83:2773-6 https://doi.org/10.1210/jc.83.8.2773
  28. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-16 https://doi.org/10.1001/jama.288.21.2709
  29. Sybert VP, McCauley E. Turner's syndrome. N Engl J Med 2004;351:1227-38 https://doi.org/10.1056/NEJMra030360
  30. Bondy CA. Care of girls and women with Turner syndrome: A guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab 2007;92:10-25